rs3833341
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_033409.4(SLC52A3):c.568-16_568-15insATTGACCTG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.565 in 1,548,112 control chromosomes in the GnomAD database, including 250,805 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.53 ( 21644 hom., cov: 0)
Exomes 𝑓: 0.57 ( 229161 hom. )
Consequence
SLC52A3
NM_033409.4 intron
NM_033409.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.279
Publications
2 publications found
Genes affected
SLC52A3 (HGNC:16187): (solute carrier family 52 member 3) This gene encodes a riboflavin transporter protein that is strongly expressed in the intestine and likely plays a role in intestinal absorption of riboflavin. The protein is predicted to have eleven transmembrane domains and a cell surface localization signal in the C-terminus. Mutations at this locus have been associated with Brown-Vialetto-Van Laere syndrome and Fazio-Londe disease. [provided by RefSeq, Mar 2012]
SLC52A3 Gene-Disease associations (from GenCC):
- Brown-Vialetto-van Laere syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
- progressive bulbar palsyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 20-764018-A-ACAGGTCAAT is Benign according to our data. Variant chr20-764018-A-ACAGGTCAAT is described in ClinVar as Benign. ClinVar VariationId is 262235.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.578 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.530 AC: 80258AN: 151294Hom.: 21633 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
80258
AN:
151294
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.569 AC: 795082AN: 1396702Hom.: 229161 Cov.: 45 AF XY: 0.567 AC XY: 390260AN XY: 688012 show subpopulations
GnomAD4 exome
AF:
AC:
795082
AN:
1396702
Hom.:
Cov.:
45
AF XY:
AC XY:
390260
AN XY:
688012
show subpopulations
African (AFR)
AF:
AC:
14730
AN:
31622
American (AMR)
AF:
AC:
12656
AN:
35928
Ashkenazi Jewish (ASJ)
AF:
AC:
15161
AN:
25068
East Asian (EAS)
AF:
AC:
20506
AN:
35880
South Asian (SAS)
AF:
AC:
39546
AN:
79890
European-Finnish (FIN)
AF:
AC:
26291
AN:
49748
Middle Eastern (MID)
AF:
AC:
3015
AN:
5090
European-Non Finnish (NFE)
AF:
AC:
629691
AN:
1075598
Other (OTH)
AF:
AC:
33486
AN:
57878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
16013
32026
48038
64051
80064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17546
35092
52638
70184
87730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.530 AC: 80300AN: 151410Hom.: 21644 Cov.: 0 AF XY: 0.524 AC XY: 38780AN XY: 73980 show subpopulations
GnomAD4 genome
AF:
AC:
80300
AN:
151410
Hom.:
Cov.:
0
AF XY:
AC XY:
38780
AN XY:
73980
show subpopulations
African (AFR)
AF:
AC:
19402
AN:
41300
American (AMR)
AF:
AC:
6527
AN:
15242
Ashkenazi Jewish (ASJ)
AF:
AC:
2115
AN:
3460
East Asian (EAS)
AF:
AC:
3021
AN:
5112
South Asian (SAS)
AF:
AC:
2459
AN:
4802
European-Finnish (FIN)
AF:
AC:
5547
AN:
10532
Middle Eastern (MID)
AF:
AC:
158
AN:
288
European-Non Finnish (NFE)
AF:
AC:
39449
AN:
67672
Other (OTH)
AF:
AC:
1151
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1903
3807
5710
7614
9517
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
716
1432
2148
2864
3580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1743
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Pathogenic:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Brown-Vialetto-van Laere syndrome 1 Pathogenic:1Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 17, 2015
GeneReviews
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
not provided Benign:1
Jul 03, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.